Guided Therapeutics Inc. (GTHP)
OTC PINK OTC PINK Primary Summary
GTHP Chart
Guided Therapeutics Receives Order and Full Payment From Indonesia for 4 LuViva Systems and 1,200 Disposables
PEACHTREE CORNERS, Ga.--(BUSINESS WIRE)--Guided Therapeutics, Inc. (OTCQB: GTHP), the maker of the LuViva Advanced Cervical Scan, announced today that it had received full payment from its Indonesian distribution partner for four LuViva devices and 1,200 single-use cervical guides. Delivery of the systems is expected to occur in the first quarter of 2025. This initial shipment of LuViva devices for the government healthcare system in Sulawesi will be utilized to identify women with cervical can.
Guided Therapeutics Inc. Dividends
Guided Therapeutics Inc. Earnings
| 12 May 2025 Date | | - Cons. EPS | - EPS |
| 26 Mar 2025 Date | | - Cons. EPS | - EPS |
| 11 Nov 2024 Date | | - Cons. EPS | - EPS |
| 14 Aug 2024 Date | | - Cons. EPS | - EPS |
| 12 Aug 2024 Date | | - Cons. EPS | - EPS |
| 12 May 2025 Date | | - Cons. EPS | - EPS |
| 26 Mar 2025 Date | | - Cons. EPS | - EPS |
| 11 Nov 2024 Date | | - Cons. EPS | - EPS |
| 14 Aug 2024 Date | | - Cons. EPS | - EPS |
| 12 Aug 2024 Date | | - Cons. EPS | - EPS |
Guided Therapeutics Inc. (GTHP) FAQ
What is the stock price today?
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
Has Guided Therapeutics Inc. ever had a stock split?
Guided Therapeutics Inc. Profile
| Medical - Devices Industry | Healthcare Sector | Dr. Mark L. Faupel Ph.D. CEO | OTC PINK Exchange | 40171F501 Cusip |
| US Country | 4 Employees | - Last Dividend | - Last Split | - IPO Date |
Overview
Guided Therapeutics, Inc. is an innovative medical technology company primarily focused on the development and commercialization of non-invasive diagnostic devices. The inception of this company traces back to 1992 under the name SpectRx, Inc., before it underwent a name change to Guided Therapeutics, Inc. in February 2008. Situated in Norcross, Georgia, the company is dedicated to advancing the early detection of diseases through their groundbreaking technologies, with a particular emphasis on the detection of cervical cancer. Their mission is to enhance the quality of care for patients by providing painless, non-invasive, and point-of-care diagnostic solutions.
Products and Services
- LuViva
LuViva is the flagship product of Guided Therapeutics, Inc., representing a cutting-edge approach to the early detection of cervical cancer and its precancerous states. This non-invasive medical device is designed to scan the cervix using specific wavelengths of light, capturing the reflective and fluorescent properties inherent to healthy or diseased cervical tissue. The core benefit of LuViva lies in its ability to provide immediate results without the discomfort or invasiveness of traditional biopsy methods, thereby streamlining the diagnostic process and facilitating early intervention. This tool exemplifies the company's dedication to improving patient outcomes through innovative medical technology.
Contact Information
